5-Nov-2025 3:05 PM CST - Business Wire Innoviva Reports Third Quarter 2025 Financial Results; Highlights Recent Company Progress Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today reported financial results for the third quarter ended September 30, 2025, and highlighted select corporate progress and achievements. Innoviva delivered strong t
26-Aug-2025 6:00 AM CST - Business Wire Innoviva to Participate in Upcoming Investor Conferences Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that management will participate in the following upcoming investor conferences in September: Citi's 2025 Biopharma Back to School Conference Format: Fir
6-Aug-2025 3:05 PM CST - Business Wire Innoviva Reports Second Quarter 2025 Financial Results; Highlights Recent Company Progress Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today reported financial results for the second quarter ended June 30, 2025, and highlighted select corporate progress and achievements. Innoviva continued to deliver i
3-Jun-2025 6:00 AM CST - Business Wire Innoviva to Participate in Upcoming Investor Conferences Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that management will participate in the following upcoming investor conferences in June: Goldman Sachs 46th Annual Global Healthcare Conference 2025 Form
7-May-2025 3:05 PM CST - Business Wire Innoviva Reports First Quarter 2025 Financial Results; Highlights Recent Company Progress Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today reported financial results for the first quarter ended March 31, 2025, and highlighted select corporate progress and achievements. We are pleased with our strong
5-Mar-2025 6:00 AM CST - Business Wire Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a fireside chat at the Barclays 27th Annual Global Healthcare Conference in Miami, FL on
26-Feb-2025 3:04 PM CST - Business Wire Innoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company Progress Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today reported financial results for the fourth quarter and full year ended December 31, 2024, and highlighted select corporate progress and achievements. Pavel Raifeld,
6-Feb-2025 6:00 AM CST - Business Wire Innoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a podium presentation at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
26-Nov-2024 6:00 AM CST - Business Wire Innoviva to Participate in the Citi 2024 Global Healthcare Conference Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a fireside chat at the Citi 2024 Global Healthcare Conference in Miami, FL on Thursday,
Latest INVA Trades by Congress Members
25-MAR-2025 - George Whitesides, CA (District 27) sold between $250,001 and $500,000.
5-Nov-2025 3:05 PM CST - Business Wire Innoviva Reports Third Quarter 2025 Financial Results; Highlights Recent Company Progress Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today reported financial results for the third quarter ended September 30, 2025, and highlighted select corporate progress and achievements. Innoviva delivered strong t
26-Aug-2025 6:00 AM CST - Business Wire Innoviva to Participate in Upcoming Investor Conferences Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that management will participate in the following upcoming investor conferences in September: Citi's 2025 Biopharma Back to School Conference Format: Fir
6-Aug-2025 3:05 PM CST - Business Wire Innoviva Reports Second Quarter 2025 Financial Results; Highlights Recent Company Progress Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today reported financial results for the second quarter ended June 30, 2025, and highlighted select corporate progress and achievements. Innoviva continued to deliver i
3-Jun-2025 6:00 AM CST - Business Wire Innoviva to Participate in Upcoming Investor Conferences Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that management will participate in the following upcoming investor conferences in June: Goldman Sachs 46th Annual Global Healthcare Conference 2025 Form
7-May-2025 3:05 PM CST - Business Wire Innoviva Reports First Quarter 2025 Financial Results; Highlights Recent Company Progress Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today reported financial results for the first quarter ended March 31, 2025, and highlighted select corporate progress and achievements. We are pleased with our strong
5-Mar-2025 6:00 AM CST - Business Wire Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a fireside chat at the Barclays 27th Annual Global Healthcare Conference in Miami, FL on
26-Feb-2025 3:04 PM CST - Business Wire Innoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company Progress Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today reported financial results for the fourth quarter and full year ended December 31, 2024, and highlighted select corporate progress and achievements. Pavel Raifeld,
6-Feb-2025 6:00 AM CST - Business Wire Innoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a podium presentation at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
26-Nov-2024 6:00 AM CST - Business Wire Innoviva to Participate in the Citi 2024 Global Healthcare Conference Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a fireside chat at the Citi 2024 Global Healthcare Conference in Miami, FL on Thursday,
